Article

Personalized 1-2-3-Gene(s) Tickets to Cancer-Free Prostate

2021-10-01

Abstract excerpt

Many years and $$$ spent for research did not yet produced a universally effective gene therapy of prostate cancer (PCa). Our studies indicated that not only each human, but even each cancer nodule in the same tumor has unique and dynamic gene expression profile, control and coordination. The tumor heterogeneity of the transcriptome topology is a strong argument in favor of personalized gene therapies, tailored on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7f8514e4-98d9-5339-88bb-0dc9e3fc590b
DOI: 10.20944/preprints202110.0003.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Personalized 1-2-3-Gene(s) Tickets to Cancer-Free ProstateDOI 10.20944/preprints202110.0003.v1Read

Genomic Fabric Remodeling in Prostate CancerSemantic proximity Read

The Gene Master Regulators (GMR) Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene TherapySemantic proximity Read

In a Prostate Tumor, Each Cancer Clone Has Unique Transcriptomic Topology of the Immune ResponseSemantic proximity Read

CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancerSemantic proximity Read

Towards a Personalized Cancer Gene Therapy: A Case of Clear Cell Renal Cell CarcinomaSemantic proximity Read

Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery.Semantic proximity Read

Nonmonotone invasion landscape by noise-aware control of metastasis activator levelsSemantic proximity Read

Predictive and Regenerative Medicine for HumansSemantic proximity Read